Discover the latest news from the Pulmonary Hypertension, including advocacy updates, research articles and event coverage.
The latest issue of Advances in Pulmonary Hypertension addresses how non-medical factors can influence PH care, such as social factors, diet and exercise, and caregiving. Advances is PHA’s quarterly peer-reviewed clinical journal.
Nearly two-thirds of American adults don’t have an up-to-date estate plan. During National Make-A-Will Month, make time to check this important task off your to-do list. As you reflect on the people you love and causes you care about, consider including the Pulmonary Hypertension Association in your estate planning.
Jane Northrop helps answer calls on PHA’s Patient and Caregiver Support Line. : “I want to help others newly diagnosed patients feel like there is hope even with diagnosis,” says Jane, of Orlando, Florida. Find out how you can volunteer for the support line and share your knowledge and strength.
The Pulmonary Hypertension Association recently released seven new videos to help you manage your pulmonary hypertension. The seven-part series features J. Wesley McConnell, M.D., director of Norton Healthcare Pulmonary Hypertension Clinic in Louisville, Kentucky.
The Harpp family of Indianapolis and Barb Linser of Cincinnati shared their supplemental oxygen challenges in Pathlight. Their stories are typical of those who don’t have access to the most appropriate type of oxygen for their needs. Supplemental oxygen is vital for many people with PH.
The Pulmonary Hypertension Association continues (PHA) to build congressional co-sponsorship for the Safe Step and HELP Copays acts. Rep. Neal Dunn (R-Fla.) signed onto the HELP Copays Act immediately after PHA’s visits with his legislative aide. Other congressional staffers said hearing from PHA helped encourage them to bring those bills to the attention of their bosses.
Pulmovant is enrolling participants in its Phase 3 mosliciguat study after positive Phase 2 results.
The FDA will review United Therapeutic’s new drug application for Ralinepag, a once-daily pill to treat PAH.
Study suggests transdermal delivery could be alternative to existing treprostinil administration methods.
